“减肥双雄”财报打消市场忧虑,焦点转向下一代产品

华尔街见闻
07 Feb

减肥药市场持续增长,焦点转向下一代产品。 近日,“减肥双雄”诺和诺德和礼来双双发布财报,诺和诺德预计2025年公司整体销售额将增长20%,礼来则预计今年收入将增长约32%。 诺和诺德美国区负责人David Moore在分析师电话会议上指出,目前仅有120万患者正在使用公司的肥胖药物Wegovy,而有5500万人的保险可以覆盖该药物,这意味着市场潜力巨大。 礼来则报告称,公司在新GLP-1处方药市场...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10